Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a complex disease associated with premature mortality. Its diagnosis is challenging, and the identification of biomarkers causally influenced by NAFLD may be clinically useful. We aimed at identifying blood metabolites causally impacted by NAFLD using two...

詳細記述

書誌詳細

主要な著者:	Émilie Gobeil, Ina Maltais-Payette, Nele Taba, Francis Brière, Nooshin Ghodsian, Erik Abner, Jérôme Bourgault, Eloi Gagnon, Hasanga D. Manikpurage, Christian Couture, Patricia L. Mitchell, Patrick Mathieu, François Julien, Jacques Corbeil, Marie-Claude Vohl, Sébastien Thériault, Tõnu Esko, André Tchernof, Benoit J. Arsenault
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-05-01
シリーズ:	Metabolites
主題:	non-alcoholic fatty liver disease tyrosine biomarker metabolites obesity Mendelian randomization
オンライン･アクセス:	https://www.mdpi.com/2218-1989/12/5/440
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!